These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32498363)

  • 21. [Relationship between epithelial-mesenchymal transition and basal cell-like phenotype in breast cancer].
    Wu WX; Zhang YP; Wen XW; Lu N; Tang ZY; Zhang Y; Wang Z; Wang W; Yang HJ
    Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):519-23. PubMed ID: 20021961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulatory effect of puerarin on bone formation through co-activation of nitric oxide and bone morphogenetic protein-2/mitogen-activated protein kinases pathways in mice.
    Sheu SY; Tsai CC; Sun JS; Chen MH; Liu MH; Sun MG
    Chin Med J (Engl); 2012 Oct; 125(20):3646-53. PubMed ID: 23075718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of SDF-1 activates the NF-κB pathway to induce epithelial to mesenchymal transition and cancer stem cell-like phenotypes of breast cancer cells.
    Kong L; Guo S; Liu C; Zhao Y; Feng C; Liu Y; Wang T; Li C
    Int J Oncol; 2016 Mar; 48(3):1085-94. PubMed ID: 26782945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ratio of transforming growth factor-β1/bone morphogenetic protein-7 in the progression of the epithelial-mesenchymal transition contributes to rat liver fibrosis.
    Bi WR; Xu GT; Lv LX; Yang CQ
    Genet Mol Res; 2014 Feb; 13(1):1005-14. PubMed ID: 24634122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of stromal cell components of tumor microenvironment on epithelial-mesenchymal transition in breast cancer cells.
    Bezdenezhnykh N; Semesiuk N; Lykhova O; Zhylchuk V; Kudryavets Y
    Exp Oncol; 2014 Jun; 36(2):72-8. PubMed ID: 24980759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Icariin isolated from Epimedium pubescens regulates osteoblasts anabolism through BMP-2, SMAD4, and Cbfa1 expression.
    Hsieh TP; Sheu SY; Sun JS; Chen MH; Liu MH
    Phytomedicine; 2010 May; 17(6):414-23. PubMed ID: 19747809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone Morphogenetic Protein-7 Suppresses TGFβ2-Induced Epithelial-Mesenchymal Transition in the Lens: Implications for Cataract Prevention.
    Shu DY; Wojciechowski MC; Lovicu FJ
    Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):781-796. PubMed ID: 28152139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
    Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
    Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secretory pathway Ca
    Dang D; Prasad H; Rao R
    Mol Carcinog; 2017 Nov; 56(11):2474-2485. PubMed ID: 28618103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.
    Jang MH; Kim HJ; Kim EJ; Chung YR; Park SY
    Hum Pathol; 2015 Sep; 46(9):1267-74. PubMed ID: 26170011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancer-initiating cells.
    Cuyàs E; Corominas-Faja B; Martín MM; Martin-Castillo B; Lupu R; Brunet J; Bosch-Barrera J; Menendez JA
    Oncotarget; 2017 May; 8(21):35019-35032. PubMed ID: 28388533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transforming growth factor-β1 suppresses bone morphogenetic protein-2-induced mesenchymal-epithelial transition in HSC-4 human oral squamous cell carcinoma cells via Smad1/5/9 pathway suppression.
    Chiba T; Ishisaki A; Kyakumoto S; Shibata T; Yamada H; Kamo M
    Oncol Rep; 2017 Feb; 37(2):713-720. PubMed ID: 28035402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
    Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
    Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incomplete epithelial-mesenchymal transition in p16-positive squamous cell carcinoma cells correlates with β-catenin expression.
    Umbreit C; Flanjak J; Weiss C; Erben P; Aderhold C; Faber A; Stern-Straeter J; Hoermann K; Schultz JD
    Anticancer Res; 2014 Dec; 34(12):7061-9. PubMed ID: 25503133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone morphogenetic protein 7 attenuates epithelial-mesenchymal transition induced by silica.
    Yang G; Zhu Z; Wang Y; Gao A; Niu P; Chen L; Tian L
    Hum Exp Toxicol; 2016 Jan; 35(1):69-77. PubMed ID: 25733726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer.
    Ryu HS; Park DJ; Kim HH; Kim WH; Lee HS
    Hum Pathol; 2012 Apr; 43(4):520-8. PubMed ID: 22018628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gremlin-1: An endogenous BMP antagonist induces epithelial-mesenchymal transition and interferes with redifferentiation in fetal RPE cells with repeated wounds.
    Li D; Yuan D; Shen H; Mao X; Yuan S; Liu Q
    Mol Vis; 2019; 25():625-635. PubMed ID: 31700227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The number of polyploid giant cancer cells and epithelial-mesenchymal transition-related proteins are associated with invasion and metastasis in human breast cancer.
    Fei F; Zhang D; Yang Z; Wang S; Wang X; Wu Z; Wu Q; Zhang S
    J Exp Clin Cancer Res; 2015 Dec; 34():158. PubMed ID: 26702618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epithelial-Mesenchymal Transition in Non Small-cell Lung Cancer.
    Tsoukalas N; Aravantinou-Fatorou E; Tolia M; Giaginis C; Galanopoulos M; Kiakou M; Kostakis ID; Dana E; Vamvakaris I; Korogiannos A; Tsiambas E; Salemis N; Kyrgias G; Karameris A; Theocharis S
    Anticancer Res; 2017 Apr; 37(4):1773-1778. PubMed ID: 28373440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Receptor activator of NF-kappaB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells.
    Odero-Marah VA; Wang R; Chu G; Zayzafoon M; Xu J; Shi C; Marshall FF; Zhau HE; Chung LW
    Cell Res; 2008 Aug; 18(8):858-70. PubMed ID: 18645583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.